Funder
National Institutes of Health
NIH
National Institute of Mental Health
Publisher
Springer Science and Business Media LLC
Subject
Virology,Cellular and Molecular Neuroscience,Neurology (clinical),Neurology
Reference42 articles.
1. Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RW, Pulliam L, Robertson KR, Sacktor N, Valcour V, Wojna VE (2007) Updated research nosology for HIV-associated neurocognitive disorders. J Neurol 69(18):1789–1799
2. Benedict RH, Morrow SA, Weinstock Guttman B, Cookfair D, Schretlen DJ (2010) Cognitive reserve moderates decline in information processing speed in multiple sclerosis patients. J Int Neuropsychol Soc 16(5):829–835
3. Brown LA, Jin J, Ferrell D, Sadic E, Obregon D, Smith AJ, Tan J, Giunta B (2014) Efavirenz promotes β-secretase expression and increased Aβ1-40,42 via oxidative stress and reduced microglial phagocytosis: implications for HIV associated neurocognitive disorders (HAND). PLoS ONE 9(4):e95500
4. Casaletto KB, Weber E, Iudicello JE, Woods SP (2017) Real-world impact of HIV-associated neurocognitive impairment. Changes in the brain: impact on daily life. J Neurovirol: 211–45
5. Chapko D, McCormack R, Black C, Staff R, Murray A (2018) Life-course determinants of cognitive reserve (CR) in cognitive aging and dementia - a systematic literature review. Aging Ment Health 22(8):915–926